Dr. Andre Ghantous, M.D.
Cardiology (Cardiovascular Disease Physician)
- Medicare participating
At a glance
- Years since graduation
- 36
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 524
Licensed in Connecticut since 1996, according to the Connecticut Department of Public Health. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
CT license 035612 (first issued 1996; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Yale-New Haven Hospital New Haven, CT
- Hartford Hospital Hartford, CT
- The Hospital of Central Connecticut New Britain, CT
- Midstate Medical Center Meriden, CT
Medical groups
- Hartford Healthcare Medical Group Specialists PLLC (1,588 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 524
- Services billed
- 1,398
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 266 | 189 |
| Established patient office or other outpatient visit, 30-39 minutes | 193 | 119 |
| Remote monitoring of pulmonary artery pressure sensor, up to 30 days | 170 | 19 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 107 | 106 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 88 | 83 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 42 | 42 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 27 | 26 |
| Established patient office or other outpatient visit, 20-29 minutes | 24 | 23 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 24 | 24 |
| Injection, perflutren lipid microspheres, per ml | 21 | 16 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Metoprolol Succinate Other prescribers in New Haven, CT | 163 |
| Eliquis (apixaban) Other prescribers in New Haven, CT | 129 |
| Rosuvastatin Calcium Other prescribers in New Haven, CT | 121 |
| Amlodipine Besylate Other prescribers in New Haven, CT | 116 |
| Atorvastatin Calcium Other prescribers in New Haven, CT | 104 |
| Farxiga (dapagliflozin propanediol) Other prescribers in New Haven, CT | 97 |
| Entresto (sacubitril/valsartan) Other prescribers in New Haven, CT | 87 |
| Valsartan Other prescribers in New Haven, CT | 86 |
| Spironolactone Other prescribers in New Haven, CT | 77 |
| Jardiance (empagliflozin) Other prescribers in New Haven, CT | 69 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 18 companies reported 61 payments worth $2,449 in total to this clinician.
| Boston Scientific Corporation | $1,084 |
|---|---|
| Abbott Laboratories | $336 |
| Merck Sharp & Dohme LLC | $166 |
| Novartis Pharmaceuticals Corporation | $135 |
| Novo Nordisk Inc | $99.85 |
| Alnylam Pharmaceuticals Inc. | $88.01 |
| Lilly USA, LLC | $80.16 |
| Heartflow, Inc. | $70.14 |
| Food and Beverage | $1,694 |
|---|---|
| Travel and Lodging | $755 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Boston Scientific Corporation Dec 5, 2025 | Travel and Lodging WATCHMAN FLX · WATCHMAN FLX_IC · travel to New York, NY · in-kind | $670 |
| Boston Scientific Corporation Dec 5, 2025 | Travel and Lodging WATCHMAN FLX · WATCHMAN FLX_IC · travel to New York, NY · in-kind | $85.00 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.